cbdMD, Inc.
YCBD
$0.49
-$0.01-1.56%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.55M | 5.64M | 5.02M | 4.72M | 4.61M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.55M | 5.64M | 5.02M | 4.72M | 4.61M |
| Cost of Revenue | 2.52M | 2.38M | 2.02M | 1.94M | 1.78M |
| Gross Profit | 3.04M | 3.26M | 3.00M | 2.78M | 2.83M |
| SG&A Expenses | 3.83M | 3.75M | 2.97M | 2.97M | 3.12M |
| Depreciation & Amortization | 259.00K | 251.60K | 245.40K | 262.10K | 280.20K |
| Other Operating Expenses | 71.00K | 50.20K | 72.80K | 217.00K | 322.80K |
| Total Operating Expenses | 6.68M | 6.44M | 5.30M | 5.41M | 5.51M |
| Operating Income | -1.13M | -800.80K | -286.30K | -685.80K | -904.70K |
| Income Before Tax | -1.13M | -798.00K | -283.10K | -680.00K | -895.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.13M | -798.00K | -283.10K | -680.00K | -895.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.13M | -798.00K | -283.10K | -680.00K | -895.30K |
| EBIT | -1.13M | -800.80K | -286.30K | -685.80K | -904.70K |
| EBITDA | -871.50K | -549.20K | -40.80K | -423.80K | -624.50K |
| EPS Basic | -0.11 | -0.08 | -0.04 | -0.08 | -0.21 |
| Normalized Basic EPS | -0.07 | -0.05 | -0.02 | -0.05 | -0.10 |
| EPS Diluted | -0.11 | -0.08 | -0.04 | -0.08 | -0.21 |
| Normalized Diluted EPS | -0.07 | -0.05 | -0.02 | -0.05 | -0.10 |
| Average Basic Shares Outstanding | 10.62M | 10.44M | 9.00M | 8.96M | 5.78M |
| Average Diluted Shares Outstanding | 10.62M | 10.44M | 9.00M | 8.96M | 5.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -10.67% | -- | -- | -- | -- |